Placement Completed
Neurizon Therapeutics placement (September 2025)
A$5m raised
Announced 18 Sep 2025 · ASX: NUZ · A$0.12 cash per share
Advisers
Neurizon Therapeutics
Issuer
Not disclosed
Lead managers
- Lead manager
- Bookrunner
- Issuer
- Neurizon Therapeutics
- Issuer based in
- Australia
- Completed
- 23 Sep 2025
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Silexion Therapeutics Corp equity raising A$3.6m · Biotech
- Odyssey Therapeutics placement May 2026 · A$35m · Biotech
- Adial Pharmaceuticals placement Jun 2026 · A$44.6m · Biotech
- Ensysce Biosciences placement Aug 2026 · A$61.2m · Biotech
- Skye Bioscience placement Aug 2026 · A$96m · Biotech
Sources
- 18 Sep 2025 Neurizon Raises $5m via Institutional Placement ASX
- 23 Sep 2025 Application for quotation of securities - NUZ ASX
